Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy

Gilead Sciences - 27 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Gilead Sciences as of March 19, 2019 is 65.49.
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 66.8057 63.4400 70.0500 62.5300 65.4900 4.70%
2018 72.4550 71.8230 86.0713 60.5400 62.5500 -9.92%
2017 69.0094 69.8347 81.7515 60.8436 69.4386 2.97%
2016 77.6107 90.2269 94.6147 67.1529 67.4334 -27.61%
2015 97.2518 86.3445 111.5870 86.3445 93.1544 8.63%
2014 81.4943 68.4224 103.9118 59.5705 85.7531 25.51%
2013 51.0011 34.1430 68.4133 34.0929 68.3223 104.49%
2012 25.7100 19.0411 34.7252 19.0411 33.4106 79.45%
2011 18.1622 16.6393 19.6552 16.0753 18.6181 12.94%
2010 17.8632 19.6961 22.4936 14.4787 16.4847 -16.25%
2009 20.9767 23.7354 24.0174 18.8500 19.6825 -15.39%
2008 22.3728 20.6241 25.9734 17.0442 23.2623 11.15%
2007 18.0039 14.3627 21.7158 14.2672 20.9288 41.72%
2006 14.0807 12.4408 15.8638 12.2248 14.7675 23.51%
2005 9.6150 7.8989 12.6524 7.0597 11.9564 50.24%
2004 7.3176 6.5980 8.8792 5.8861 7.9580 20.08%
2003 5.8553 3.9677 7.9592 3.6731 6.6275 71.41%
2002 3.8727 3.4929 4.5158 3.0192 3.8664 3.47%
2001 2.8512 2.1075 4.1058 1.5369 3.7368 58.47%
2000 2.1420 1.6009 3.3035 1.2350 2.3580 53.23%
1999 1.5176 1.1301 2.6263 1.0164 1.5389 31.83%
1998 0.9068 1.0840 1.2296 0.5188 1.1673 7.35%
1997 0.8913 0.6965 1.3115 0.6149 1.0874 53.00%
1996 0.8062 0.9274 1.1585 0.4904 0.7107 -21.88%
1995 0.5241 0.2665 0.9169 0.2665 0.9098 236.84%
1994 0.2860 0.3412 0.3980 0.1990 0.2701 -20.84%
1993 0.4206 0.5188 0.5439 0.3056 0.3412 -37.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $82.934B $22.127B
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The Company strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead's portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $119.048B 13.28
Biogen (BIIB) United States $64.057B 12.41
Celgene (CELG) United States $61.800B 11.43
Vertex Pharmaceuticals (VRTX) United States $47.931B 64.21
Illumina (ILMN) United States $44.950B 53.46
Regeneron Pharmaceuticals (REGN) United States $44.541B 20.69
Alexion Pharmaceuticals (ALXN) United States $29.835B 18.49
Incyte (INCY) United States $18.327B 171.24
BioMarin Pharmaceutical (BMRN) United States $16.653B 0.00
Seattle Genetics (SGEN) United States $11.793B 0.00
Exact Sciences (EXAS) United States $11.561B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.589B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
Sarepta Therapeutics (SRPT) United States $9.041B 0.00
QIAGEN (QGEN) Netherlands $8.950B 29.62
Bluebird Bio (BLUE) United States $8.582B 0.00
BeiGene (BGNE) Cayman Islands $8.021B 0.00
Guardant Health (GH) United States $8.018B 0.00
Bio-Techne Corp (TECH) United States $7.430B 50.06
Moderna (MRNA) United States $7.297B 0.00
Exelixis (EXEL) United States $7.245B 16.88
Amarin (AMRN) Ireland $6.232B 0.00
Ascendis Pharma (ASND) Denmark $5.428B 0.00
Alkermes (ALKS) Ireland $5.401B 0.00
Galapagos (GLPG) Belgium $5.181B 0.00
Array BioPharma (ARRY) United States $5.180B 0.00
Horizon Pharma Public (HZNP) Ireland $4.692B 15.11
Spark Therapeutics (ONCE) United States $4.326B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.304B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.899B 0.00
Blueprint Medicines (BPMC) United States $3.644B 0.00
Immunomedics (IMMU) United States $3.588B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.505B 0.00
China Biologic Products (CBPO) China $3.423B 21.21
Intercept Pharmaceuticals (ICPT) United States $3.372B 0.00
Allogene Therapeutics (ALLO) United States $3.259B 0.00
Amicus Therapeutics (FOLD) United States $3.027B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.982B 0.00
Global Blood Therapeutics (GBT) United States $2.979B 0.00
Reata Pharmaceuticals (RETA) United States $2.832B 0.00
Genomic Health (GHDX) United States $2.739B 70.03
Akcea Therapeutics (AKCA) United States $2.694B 0.00
Mirati Therapeutics (MRTX) United States $2.691B 0.00
Repligen (RGEN) United States $2.609B 80.28
Ligand Pharmaceuticals (LGND) United States $2.548B 19.03
Emergent Biosolutions (EBS) United States $2.536B 21.17
Myriad Genetics (MYGN) United States $2.485B 25.31
UniQure (QURE) Netherlands $2.475B 0.00
Acceleron Pharma (XLRN) United States $2.425B 0.00
Halozyme Therapeutics (HALO) United States $2.396B 0.00
Denali Therapeutics (DNLI) United States $2.329B 0.00
Insmed (INSM) United States $2.307B 0.00
Arena Pharmaceuticals (ARNA) United States $2.274B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.188B 0.00
MyoKardia (MYOK) United States $2.172B 0.00
REGENXBIO (RGNX) United States $2.125B 22.19
Medicines (MDCO) United States $2.004B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.980B 0.00
AnaptysBio (ANAB) United States $1.970B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.929B 0.00
NeoGenomics (NEO) United States $1.868B 151.92
Atara Biotherapeutics (ATRA) United States $1.809B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.737B 0.00
Allakos (ALLK) United States $1.710B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Puma Biotechnology (PBYI) United States $1.631B 0.00
Myovant Sciences (MYOV) United Kingdom $1.594B 0.00
WAVE Life Sciences (WVE) Singapore $1.589B 0.00
Clovis Oncology (CLVS) United States $1.453B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.446B 0.00
Innoviva (INVA) United States $1.434B 3.95
Momenta Pharmaceuticals (MNTA) United States $1.431B 0.00
GOSSAMER BIO (GOSS) United States $1.398B 0.00
Aimmune Therapeutics (AIMT) United States $1.393B 0.00
Rubius Therapeutics (RUBY) United States $1.386B 0.00
Cambrex (CBM) United States $1.328B 14.29
ALECTOR INC (ALEC) United States $1.286B 0.00
Lion Biotechnologies (IOVA) United States $1.277B 0.00
Apellis Pharmaceuticals (APLS) United States $1.249B 0.00
Fate Therapeutics (FATE) United States $1.194B 0.00
Editas Medicine (EDIT) United States $1.177B 0.00
RA PHARMCTL INC (RARX) United States $1.134B 0.00
Codexis (CDXS) United States $1.128B 0.00
Epizyme (EPZM) United States $1.113B 0.00
InflaRx (IFRX) Germany $1.089B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.042B 0.00
Coherus BioSciences (CHRS) United States $1.032B 0.00
Sangamo Therapeutics (SGMO) United States $1.002B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.994B 0.00
Retrophin (RTRX) United States $0.992B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.983B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.970B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.966B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.959B 38.77
Alder BioPharmaceuticals (ALDR) United States $0.939B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.894B 0.00
Principia Biopharma (PRNB) United States $0.872B 0.00
Vericel (VCEL) United States $0.843B 0.00
Athenex (ATNX) United States $0.831B 0.00
Cellectis (CLLS) France $0.822B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.814B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.810B 0.00
Intellia Therapeutics (NTLA) United States $0.756B 0.00
Cara Therapeutics (CARA) United States $0.754B 0.00
ANI Pharmaceuticals (ANIP) United States $0.751B 13.75
Eidos Therapeutics (EIDX) United States $0.742B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.723B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.712B 0.00
Intra-Cellular Therapies (ITCI) United States $0.707B 0.00
Revance Therapeutics (RVNC) United States $0.704B 0.00
Synthorx (THOR) United States $0.691B 0.00
Acorda Therapeutics (ACOR) United States $0.685B 8.88
Osiris Therapeutics (OSIR) United States $0.657B 0.00
Heska (HSKA) United States $0.632B 56.66
ZIOPHARM Oncology Inc (ZIOP) United States $0.625B 0.00
Twist Bioscience (TWST) United States $0.613B 0.00
Magenta Therapeutics (MGTA) United States $0.612B 0.00
Viking Therapeutics (VKTX) United States $0.612B 0.00
Kura Oncology (KURA) United States $0.609B 0.00
G1 THERAPEUTICS (GTHX) United States $0.596B 0.00
ObsEva SA (OBSV) Switzerland $0.585B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.582B 0.00
MeiraGTx Holdings (MGTX) United States $0.581B 0.00
Prothena (PRTA) Ireland $0.578B 0.00
Arvinas (ARVN) United States $0.534B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.525B 0.00
UROGEN PHARMA (URGN) Israel $0.524B 0.00
Arcus Biosciences (RCUS) United States $0.524B 0.00
Senesco Technologies (ELOX) United States $0.500B 0.00
Dynavax Technologies (DVAX) United States $0.498B 0.00
Zymeworks (ZYME) Canada $0.497B 0.00
Mesoblast (MESO) Australia $0.487B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.485B 0.00
Zealand Pharma (ZEAL) Denmark $0.482B 5.31
Scholar Rock Holding (SRRK) United States $0.481B 0.00
PDL BioPharma (PDLI) United States $0.465B 10.37
Five Prime Therapeutics (FPRX) United States $0.461B 0.00
Cytokineticsorporated (CYTK) United States $0.452B 0.00
Anika Therapeutics (ANIK) United States $0.433B 16.39
AMAG Pharmaceuticals (AMAG) United States $0.432B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.424B 0.00
AVROBIO (AVRO) United States $0.422B 0.00
Urovant Sciences (UROV) United States $0.420B 0.00
Replimune (REPL) United States $0.416B 0.00
Stemline Therapeutics (STML) United States $0.410B 0.00
MannKind (MNKD) United States $0.403B 0.00
STEALTH BIOTHER (MITO) United States $0.390B 0.00
Abeona Therapeutics (ABEO) United States $0.388B 0.00
Gritstone Oncology (GRTS) United States $0.387B 0.00
BeyondSpring (BYSI) United States $0.384B 0.00
Axsome Therapeutics (AXSM) United States $0.382B 0.00
Albireo Pharma (ALBO) United States $0.373B 0.00
UNITY Biotechnology (UBX) $0.372B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Solid Biosciences (SLDB) United States $0.369B 0.00
Kadmon Holdings (KDMN) United States $0.369B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.366B 0.00
MediciNova (MNOV) United States $0.364B 0.00
Adverum Biotechnologies (ADVM) United States $0.357B 0.00
Kezar Life Sciences (KZR) United States $0.355B 0.00
XBiotech (XBIT) United States $0.355B 0.00
BioDelivery Sciences (BDSI) United States $0.348B 0.00
Agenus (AGEN) United States $0.346B 0.00
Kindred Biosciences (KIN) United States $0.344B 0.00
Inovio Pharmaceuticals (INO) United States $0.344B 0.00
Sorrento Therapeutics (SRNE) United States $0.336B 0.00
OSMOTICA PHARM (OSMT) United States $0.325B 0.00
Aduro Biotech (ADRO) United States $0.319B 0.00
Cellular Biomedicine (CBMG) United States $0.314B 0.00
Krystal Biotech (KRYS) United States $0.307B 0.00
Geron (GERN) United States $0.306B 0.00
AC Immune SA (ACIU) Switzerland $0.305B 0.00
Strongbridge Biopharma (SBBP) United States $0.294B 0.00
Syros Pharmaceuticals (SYRS) United States $0.294B 0.00
Merus (MRUS) Netherlands $0.290B 0.00
Kala Pharmaceuticals (KALA) United States $0.289B 0.00
Protagonist Therapeutics (PTGX) United States $0.284B 0.00
Gamida Cell (GMDA) Israel $0.277B 0.00
Evelo Biosciences (EVLO) United States $0.276B 0.00
Liquidia Technologies (LQDA) United States $0.275B 0.00
Seres Therapeutics (MCRB) United States $0.270B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.269B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.268B 0.00
Enochian BioSciences (ENOB) United States $0.265B 0.00
Constellation Pharmaceuticals (CNST) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
ResTORbio (TORC) United States $0.254B 0.00
Verastem (VSTM) United States $0.250B 0.00
TOCAGEN INC (TOCA) United States $0.249B 0.00
BioTime (BTX) United States $0.243B 0.00
Mersana Therapeutics (MRSN) United States $0.241B 0.00
Kamada (KMDA) Israel $0.238B 10.74
Peregrine Pharmaceuticals (CDMO) United States $0.237B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.236B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.234B 0.00
Cerecor (CERC) United States $0.233B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.231B 0.00
Athersys (ATHX) United States $0.225B 0.00
LogicBio Therapeutics (LOGC) United States $0.224B 0.00
Spero Therapeutics (SPRO) United States $0.222B 0.00
Intec Pharma (NTEC) Israel $0.222B 0.00
ChromaDex (CDXC) United States $0.221B 0.00
Arbutus Biopharma (ABUS) Canada $0.217B 0.00
Axovant Sciences (AXGT) United Kingdom $0.216B 0.00
Celyad SA (CYAD) Belgium $0.216B 0.00
Proteostasis Therapeutics (PTI) United States $0.213B 0.00
Celcuity (CELC) United States $0.206B 0.00
Synlogic (SYBX) United States $0.203B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.203B 0.00
Palatin Technologies (PTN) United States $0.202B 99.25
CorMedix Inc (CRMD) United States $0.200B 0.00
Novavax (NVAX) United States $0.199B 0.00
ADMA Biologics Inc (ADMA) United States $0.197B 0.00
Compugen (CGEN) Israel $0.195B 0.00
VBI Vaccines (VBIV) United States $0.193B 0.00
Menlo Therapeutics (MNLO) United States $0.186B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Cue Biopharma (CUE) United States $0.177B 0.00
OvaScience (MLND) United States $0.176B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.175B 0.00
BioXcel Therapeutics (BTAI) United States $0.162B 0.00
Chiasma (CHMA) United States $0.159B 0.00
Allena Pharmaceuticals (ALNA) United States $0.158B 0.00
Pfenex (PFNX) United States $0.155B 0.00
Trevena (TRVN) United States $0.154B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.152B 0.00
Cohbar (CWBR) United States $0.148B 0.00
Anavex Life Sciences (AVXL) United States $0.142B 0.00
Aptinyx (APTX) United States $0.141B 0.00
Eton Pharmaceuticals (ETON) United States $0.134B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.134B 0.00
Unum Therapeutics (UMRX) United States $0.130B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
XOMA (XOMA) United States $0.128B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.126B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.124B 0.00
Equillium (EQ) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
Pluristem Therapeutics (PSTI) Israel $0.116B 0.00
Catalyst Biosciences (CBIO) United States $0.114B 0.00
VolitionRX (VNRX) Singapore $0.113B 0.00
Fortress Biotech (FBIO) United States $0.113B 0.00
Mustang Bio (MBIO) United States $0.112B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
Neothetics (EVFM) United States $0.103B 0.00
NantKwest (NK) United States $0.096B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.095B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.094B 0.00
VTv Therapeutics (VTVT) United States $0.092B 0.00
Cel-Sci (CVM) United States $0.089B 0.00
Signal Genetics (MGEN) United States $0.088B 0.00
Idera Pharmaceuticals (IDRA) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.085B 0.00
Cocrystal Pharma (COCP) United States $0.084B 93.80
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Aptose Biosciences (APTO) Canada $0.083B 0.00
Alimera Sciences (ALIM) United States $0.082B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.082B 0.00
Provention Bio (PRVB) United States $0.081B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.081B 0.00
Orgenesis (ORGS) United States $0.077B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
OVID THERAPEUTC (OVID) United States $0.075B 0.00
INMUNE BIO INC (INMB) United States $0.075B 0.00
ARAVIVE, INC (ARAV) United States $0.074B 0.00
SESEN BIO, INC (SESN) United States $0.074B 0.00
Protalix BioTherapeutics (PLX) Israel $0.072B 0.00
NewLink Genetics (NLNK) United States $0.070B 0.00
Proteon Therapeutics (PRTO) United States $0.070B 0.00
Cidara Therapeutics (CDTX) United States $0.070B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.070B 0.00
Selecta Biosciences (SELB) United States $0.069B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.068B 0.00
Eyenovia (EYEN) United States $0.067B 0.00
AEterna Zentaris (AEZS) United States $0.066B 12.50
Prima BioMed (IMMP) Australia $0.065B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.065B 0.00
Ophthotech (OPHT) United States $0.065B 0.00
Vascular Biogenics (VBLT) Israel $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.058B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.057B 0.00
Alcobra (ARCT) United States $0.057B 0.00
VistaGen Therapeutics (VTGN) United States $0.056B 0.00
Zosano Pharma (ZSAN) United States $0.056B 0.00
Arsanis (XFOR) United States $0.055B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.052B 0.00
ANCHIANO THERAP (ANCN) Israel $0.052B 0.00
Clearside Biomedical (CLSD) United States $0.051B 0.00
Evogene (EVGN) Israel $0.050B 0.00
Leap Therapeutics (LPTX) United States $0.050B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.050B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Bionano Genomics (BNGO) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.048B 0.00
Entera Bio (ENTX) Israel $0.047B 0.00
Curis (CRIS) United States $0.047B 0.00
Vaccinex (VCNX) United States $0.046B 0.00
TRACON Pharmaceuticals (TCON) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.043B 0.00
Celsion (CLSN) United States $0.040B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.038B 0.00
Caladrius Biosciences (CLBS) United States $0.037B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
OncoSec Medical (ONCS) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
Sophiris Bio (SPHS) United States $0.033B 0.00
GTx (GTXI) United States $0.032B 0.00
Oncolytics Biotech (ONCY) Canada $0.031B 0.00
GENPREX INC (GNPX) United States $0.031B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.030B 0.00
Advaxis (ADXS) United States $0.030B 0.00
Adial Pharmaceuticals (ADIL) United States $0.029B 0.00
Oragenics (OGEN) United States $0.028B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
BioPharmX (BPMX) United States $0.026B 0.00
Vical (VICL) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.024B 0.00
Dare Bioscience (DARE) United States $0.024B 0.00
CytRx (CYTR) United States $0.024B 0.00
Motif Bio Plc (MTFB) United States $0.023B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Aytu Bioscience (AYTU) United States $0.021B 0.00
Benitec Biopharma (BNTC) Australia $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Apricus Biosciences (SEEL) United States $0.016B 0.00
Soligenix (SNGX) United States $0.016B 0.00
TrovaGene (TROV) United States $0.016B 0.00
Gemphire Therapeutics (GEMP) United States $0.016B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.75
Genetic Technologies (GENE) Australia $0.015B 0.00
Pulmatrix (PULM) United States $0.015B 0.00
ATyr Pharma (LIFE) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
AmpliPhi Biosciences (APHB) United States $0.011B 0.00
Neuralstem (CUR) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
Histogenics (HSGX) United States $0.007B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00
Oncobiologics (OTLK) United States $0.000B 0.00